Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
EditorialEditorial

Editorial

Xinxin Ding
Drug Metabolism and Disposition January 2021, 49 (1) 1-2; DOI: https://doi.org/10.1124/dmd.120.000298
Xinxin Ding
Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

I am honored and excited to have the opportunity to serve as the next Editor of Drug Metabolism and Disposition (DMD). One of my first scientific papers was published in DMD in 1988, when Dr. Vincent Zannoni, a member of my graduate thesis committee at the University of Michigan, was the Editor. I have published regularly in DMD since then, benefiting tremendously from the high-quality reviewing and professional manuscript handling the journal has provided. My appreciation of the enormity of what the journal offers to authors and readers in our field became more profound after I joined the editorial board as an Associate Editor in 2010, appointed by Dr. Eric Johnson. Over the years, I have learned much from my predecessors, including Dr. Vincent Zannoni, Dr. Raymond Novak, and Dr. James Halpert, who inspired me to become an editor, as well as Dr. Eric Johnson, Dr. Edward Morgan, and Dr. Jeffrey Stevens, who were great role models of dedication and commitment to the success of the journal.

Like many of you, I consider DMD one of the preferred journals in which to publish my work. This confidence in the journal is built on the knowledge that my manuscripts will be reviewed by true experts and handled by a highly experienced and dedicated professional team of editorial staff. The journal is also overseen by the American Society for Pharmacology and Experimental Therapeutics (ASPET) Board of Publications. The team is made up of Associate Editors who are all leading experts in our field. They are supported by a large international editorial board, whose members are selected based on areas of expertise, high standing in the field, and dedication to peer review. The vitality of the journal is further enhanced by a close association of the editors and editorial board members with the Drug Metabolism and Disposition Division of ASPET and several leading international conferences on relevant topic areas in the drug metabolism and disposition field, such as the “International Symposium on Microsomes and Drug Oxidations” and the “International Conference on Cytochrome P450” meeting series, which ensures that the journal covers the most current scientific content in the field.

My goal as Editor for DMD is to maintain the reputation of the journal as the leading international publication in drug metabolism and disposition and as a bedrock of the global DMD community. I am looking forward to working with my team of Associate Editors, editorial board members, and editorial staff to achieve this goal in an ever-changing landscape of scientific publication. We will strive to continue the efforts of my predecessors to increase the scientific impact of the journal, to uphold the strong tradition of rigor and reproducibility, and to embrace coverage of emerging topics and interdisciplinary research while serving all constituents of the drug metabolism and disposition field. I am confident that we will be able to accomplish these tasks, particularly knowing that I will have the continued support of a dedicated team of Associate Editors who strive to be ethical, fair, prompt, and transparent while maintaining the high scientific standards of the journal. The current Associate Editors and Review Editors, including Drs. Wayne Backes (Louisiana State University), Deepak K. Dalvie (Bristol-Myers Squibb), Robert Foti (Merck), Nina Isoherranen (University of Washington), Yurong Lai (Gilead Sciences), Steven Leeder (Children’s Mercy Research Hospital), Scott R. Obach (Pfizer Inc), Mary Paine (Washington State University), David S. Riddick (University of Toronto), John D. Schuetz (St. Jude Children’s Research Hospital), Aiming Yu (University of California, Davis), and Xiaobo Zhong (University of Connecticut), provide expertise in all major subject areas published by the journal. In time, we will add new Associate Editors as well as editorial board members as the need arises to ensure adequate coverage. Strong efforts will be made to increase board membership from researchers in earlier career stages.

A special gratitude is owed to my immediate predecessor, Dr. Jeffrey Stevens, who successfully guided the journal through a number of notable challenges. Jeff was an exemplary and diligent editor. He oversaw a major transition in the journal’s manuscript handling system; he instituted changes in the manuscript workflow to make the editorial expectations more transparent; he strengthened the recruitment of minireviews; and he added several new members to the editorial board. Jeff was also very helpful in making the leadership transition seamless for me. Appreciations are also given to two Associate Editors who transitioned off the board recently, Drs. Bruno Stieger and Namandje Bumpus, who have both served with distinction.

Footnotes

  • https://doi.org/10.1124/dmd.120.000298.

  • Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 49 (1)
Drug Metabolism and Disposition
Vol. 49, Issue 1
1 Jan 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Editorial
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
EditorialEditorial

Editorial

Xinxin Ding
Drug Metabolism and Disposition January 1, 2021, 49 (1) 1-2; DOI: https://doi.org/10.1124/dmd.120.000298

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
EditorialEditorial

Editorial

Xinxin Ding
Drug Metabolism and Disposition January 1, 2021, 49 (1) 1-2; DOI: https://doi.org/10.1124/dmd.120.000298
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Publishing in an ASPET Journal – What’s in It for You?
  • Editorial
Show more Editorial

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics